Enhanced Plasmonic Imaging Inc.

Medical diagnostic platform technology that enables early disease detection through enhanced fluorescence intensity of 100-200X relative to glass substrates.

  • Stage Prototype Ready
  • Industry Medical Devices and Equipment
  • Location Columbia, MO, US
  • Currency USD
  • Founded March 2016
  • Employees 5
  • Incorporation Type C-corp
  • Website epimaging.com

Company Summary

Our technology offers a novel way to detect trace amounts of biological and chemical analytes down to a single molecule which will translate into early disease detection and monitoring. EPI integrates a unique gratings substate that increases fluorescence intensity by 100-200X compared to glass substrates. This platform allows for ultra sensitive detection of different biomarkers and rapidly detects bacteria, viruses, proteins, and DNA.

Team

  • Rory Bloomfield

  • Cory S. Goldberg
    CEO

    Dr. Cory Goldberg is a Plastic Surgeon dual-certified in both the US and Canada, with advanced training in Craniofacial Surgery at the University of Southern California and Cedar’s Sinai. After completing medical school at Queen’s University he earned a Masters of Applied Science in Biomedical Engineering. Dr. Goldberg also recently completed an executive MBA through Cornell and Queen’s schools of business.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free